SCHEMBL6326345

SCHEMBL6326345

Cc1csc(C2=C(c3ccccc3)C(=O)C2(Cl)Cl)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.34
PTGS2 P35354 3/20 0.34
CHEK1 O14757 1/20 0.32
MAPT P10636 2/20 0.31
TP53 P04637 1/20 0.31
CCNC P24863 1/20 0.31
CDK8 P49336 1/20 0.31
ALOX5 P09917 1/20 0.30
HPGDS O60760 1/20 0.30
ALDH1A1 P00352 2/20 0.30
DAO P14920 1/20 0.30
PDE4B Q07343 1/20 0.30
KDM4E B2RXH2 1/20 0.30
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
MAPK1 P28482 1/20 0.30
BACE1 P56817 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7569141 0.86 PTGS1 (0.37) PTGS1PTGS2CHEK1ALDH1A1BACE1
SCHEMBL7568017 0.84 PTGS1 (0.47) PTGS1PTGS2CHEK1MAPTTP53
SCHEMBL7565538 0.83 PTGS1 (0.33) PTGS1PTGS2
SCHEMBL7565479 0.81 PTGS2 (0.35) PTGS1PTGS2MAPTTP53ALDH1A1
SCHEMBL7573867 0.75 PTGS1 (0.47) PTGS1PTGS2CHEK1HPGDSDAO
SCHEMBL72613 0.72 AR (0.43) DAONPC1RAB9ASMN1; SMN2TSHR
SCHEMBL7566050 0.71 ALDH2 (0.32) CHEK1MAPTTP53HPGDSDAO
SCHEMBL7566081 0.71 PTGS1 (0.46) PTGS1PTGS2CHEK1MAPTTP53
SCHEMBL5833325 0.70 KMT2A (0.56) PTGS1PTGS2ALDH1A1SMN1; SMN2
SCHEMBL6326340 0.66 PTGS2 (0.59) PTGS1PTGS2MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0889878-B1 BISARYLCYCLOBUTENE DERIVATES AS CYCLOOXYGENASE INHIBITORS MERCK FROSST CANADA INC (CA) 2002-09-04 EP claimed
WO-2000029022-A1 COX-2 INHIBITORS IN COMBINATION WITH CENTRALLY ACTING ANALGESICS ALGOS PHARMACEUTICAL CORPORATION (US) 2000-05-25 WO claimed
US-5817700-A ANTIINFLAMMATORY AGENTS MERCK FROSST CANADA, INC. (CA) 1998-10-06 US claimed
US-20050100594-A1 Pharmaceutical formulation containing muscle relaxant and COX-II inhibitor GLENMARK PHARMACEUTICALS LIMITED (IN) 2005-05-12 US disclosed
US-20050096371-A1 Topical pharmaceutical compositions GLENMARK PHARMACEUTICALS LIMITED (IN) 2005-05-05 US disclosed
EP-0889878-B1 BISARYLCYCLOBUTENE DERIVATES AS CYCLOOXYGENASE INHIBITORS MERCK FROSST CANADA INC (CA) 2002-09-04 EP disclosed
US-5817700-A ANTIINFLAMMATORY AGENTS MERCK FROSST CANADA, INC. (CA) 1998-10-06 US disclosed